Essais liés2clinical trials
VilleLuxembourglocalisation
PaysLuxembourglocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT02227758

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Prasinezumab Parkinson Phase 2 NCT04777331 PADOVA — A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease ACTIVE_NOT_RECRUITING
Relief — Peripheral Nerve Stimulation Registry for Intractable Migraine Headache Migraine À vérifier NCT02227758 Relief — Peripheral Nerve Stimulation Registry for Intractable Migraine Headache COMPLETED